Xoma | XOMA - Fremdkapital





Fremdkapital Veränderung Datum
AbbVie USD 58.94B 4.03B 2025-12
Agenus USD 169.66M 146.06M 2025-12
Agios Pharmaceuticals USD 1.06M 0 2022-09
Ardelyx USD 202.83M 696K 2025-12
aTyr Pharma USD 12.51M 12.11M 2025-12
BioMarin Pharmaceutical USD 1.43B 833.11M 2026-03
Curis USD 29.43M 10.69M 2024-06
Eli Lilly USD 39.37B 1.5B 2026-03
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Incyte USD 29.41M 785K 2026-03
MacroGenics USD 70M 256K 2025-12
Novartis USD 37.45B 7.86B 2026-03
Novartis USD 29.59B 5.35B 2025-12
Pfizer USD 60.57B 1.08B 2026-03
Prothena USD 0 0 2024-12
Regeneron Pharmaceuticals USD 1.99B 719.7M 2026-03
Xoma USD 94.38M 7.82M 2025-09